SIC 2834 – Pharmaceutical Preparations
| Valuation | |
|---|---|
| Market Cap ($M) | 13,948.73 |
| Enterprise Value ($M) | 24,027.91 |
| Book Value ($M) | 10,258.47 |
| Book Value / Share | 23.67 |
| Price / Book | 1.36 |
| NCAV ($M) | -6,078.21 |
| NCAV / Share | -14.03 |
| Price / NCAV | -2.29 |
| Profitability (mra) | |
|---|---|
| Return on Invested Capital (ROIC) | 0.05 |
| Return on Assets (ROA) | 0.05 |
| Return on Equity (ROE) | 0.09 |
| Liquidity (mrq) | |
|---|---|
| Quick Ratio | 1.44 |
| Current Ratio | 1.44 |
| Balance Sheet (mrq) ($M) | |
|---|---|
| Current Assets | 1,802.14 |
| Assets | 18,222.72 |
| Liabilities | 7,880.35 |
| Debt | n/a |
| Equity | n/a |
| Income Statement (mra) ($M) | |
|---|---|
| Revenue | 2,263.00 |
| Operating Income | 1,292.00 |
| Net Income | 859.00 |
| Earnings Per Share Diluted | n/a |
| Earnings Per Share Basic | n/a |
| Cash Flow Statement (mra) ($M) | |
|---|---|
| Cash From Operations | 2,769.00 |
| Cash from Investing | -2,678.00 |
| Cash from Financing | 361.00 |
(click for more detail) |
|
| File Date | Form | Activist 13D/G Investors | Ownership (%) |
Change (%) |
|---|---|---|---|---|
| 13D/A | Severgnini Achille G. | 8.30 | -13.56 | |
| 13G/A | Fmr Llc | 5.90 | -16.70 | |
| 13G | BlackRock, Inc. | 5.70 | ||
| 13G/A | Morgan Stanley | 8.20 | -11.28 |
| Top 13F Investors | Shares (1000) |
Change (%) |
Value ($1000) |
Change (%) |
|---|---|---|---|---|
(click for more detail) |
||||
| Date | Insider Trades | Code | Shares | Value |
|---|---|---|---|---|
(click for more detail) |
||||
| File Date | Form | SEC Filings |
|---|---|---|
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K | ||
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q | ||
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q | ||
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q | ||
(click for more detail) |
||
| Short Volume | |||
|---|---|---|---|
| Market Date | Short Volume | Total Volume | Short Volume Ratio |
| 707,151 | 2,115,646 | 33.42 | |
| 783,536 | 2,615,858 | 29.95 | |
| 650,538 | 2,422,508 | 26.85 | |
| 372,225 | 2,250,596 | 16.54 | |
(click for more detail) |
|||
| Similar Companies | |
|---|---|
| RLMD – Relmada Therapeutics, Inc. | RLYB – Rallybio Corporation |
| ROIV – Roivant Sciences Ltd. | RPTX – Repare Therapeutics Inc. |
| RVMD – Revolution Medicines, Inc. |
Financial data and stock pages provided by
Fintel.io